Time to buy GILD. Dropped too far. Remesvidir
Time to buy GILD. Remesvidir and recently bounced off a low resistance of approximately $61.
Remesvidir recently was said to reduce recovery time from Covid-19. More info: gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
Remesvidir recently was said to reduce recovery time from Covid-19. More info: gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.